Schentag, Jerome J.

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

Forrest, A., Nix, D. E., Ballow, C. H., Goss, T. F., Birmingham, M. C., & Schentag, J. J. (1993) · Antimicrobial Agents and Chemotherapy

Antibiotics Pharmacokinetics and EfficacyAntibiotic Use and Resistance

Cited by 1,101

Individualised antibiotic dosing for patients who are critically ill: Challenges and potential solutions.

Roberts, J. A., Abdul-Aziz, M. H., Lipman, J., Mouton, J. W., Vinks, A. A., Felton, T. W., Hope, W. W., Farkas, A., Neely, M. N., Schentag, J. J., et al. (2014) · The Lancet Infectious Diseases

Antibiotics Pharmacokinetics and EfficacyAntibiotic Use and Resistance

Cited by 1,046

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

McKinnon, P. S., Paladino, J. A., & Schentag, J. J. (2008) · International Journal of Antimicrobial Agents

Antibiotics Pharmacokinetics and EfficacySepsis Diagnosis and Treatment

Cited by 464

Linezolid for the Treatment of Multidrug‐Resistant, Gram‐Positive Infections: Experience from a Compassionate‐Use Program

Birmingham, M. C., Rayner, C. R., Meagher, A. K., Flavin, S. M., Batts, D. H., & Schentag, J. J. (2003) · Clinical Infectious Diseases

Antimicrobial Resistance in StaphylococcusAntibiotics Pharmacokinetics and Efficacy

Cited by 428

Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme.

Rayner, C. R., Forrest, A., Meagher, A. K., Birmingham, M. C., & Schentag, J. J. (2003) · Clinical Pharmacokinetics

Antibiotics Pharmacokinetics and EfficacyNeutropenia and Cancer Infections

Cited by 306

Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus

Monte, S. V., Caruana, J. A., Ghanim, H., Sia, C. L., Korzeniewski, K., Schentag, J. J., & Dandona, P. (2012) · Surgery

Bariatric Surgery and OutcomesAdipokines, Inflammation, and Metabolic Diseases

Cited by 143

Increase in the mediators of asthma in obesity and obesity with type 2 diabetes: Reduction with weight loss: Obesity, Diabetes and Asthma

Dandona, P., Ghanim, H., Monte, S. V., Caruana, J. A., Green, K., Abuaysheh, S., Lohano, T., Schentag, J., Dhindsa, S., & Chaudhuri, A. (2014) · Obesity

Asthma and respiratory diseasesAdipokines, Inflammation, and Metabolic Diseases

Cited by 54